Debt-to-equity of ENvue Medical, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ENvue Medical, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • ENvue Medical, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 29%, a 68% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ENvue Medical, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 29% -62% -68% 30 Sep 2025
Q2 2025 32% -41% -56% 30 Jun 2025
Q1 2025 42% -39% -48% 31 Mar 2025
Q4 2024 129% +41% +46% 31 Dec 2024
Q3 2024 91% -3% -3.2% 30 Sep 2024
Q2 2024 73% -29% -29% 30 Jun 2024
Q1 2024 81% +4.2% +5.5% 31 Mar 2024
Q4 2023 88% +28% +46% 31 Dec 2023
Q3 2023 94% +45% +93% 30 Sep 2023
Q2 2023 102% +69% +209% 30 Jun 2023
Q1 2023 76% +42% +124% 31 Mar 2023
Q4 2022 60% +17% +39% 31 Dec 2022
Q3 2022 49% -21% -30% 30 Sep 2022
Q2 2022 33% -63% -66% 30 Jun 2022
Q1 2022 34% -104% -75% 31 Mar 2022
Q4 2021 43% -126% -74% 31 Dec 2021
Q3 2021 70% -21% -23% 30 Sep 2021
Q2 2021 96% -24% -20% 30 Jun 2021
Q1 2021 138% +83% +149% 31 Mar 2021
Q4 2020 169% +90% +114% 31 Dec 2020
Q3 2020 91% -15% -14% 30 Sep 2020
Q2 2020 120% 30 Jun 2020
Q1 2020 55% 31 Mar 2020
Q4 2019 79% 31 Dec 2019
Q3 2019 106% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.